Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Society of Cardiology
Pharma
ESC: Amgen CMO touts Repatha 'inflection' on mortality data
Still, the urgency to treat patients and get them to LDL-C target remains “quite remarkably slow,” Amgen CMO Paul Burton told Fierce.
Fraiser Kansteiner
Sep 3, 2026 8:30am
Fierce Biotech
Don't count out Alnylam's next-gen silencer in ATTR-CM: analysts
Sep 1, 2026 1:55pm
ESC: AZ digs deep on Wainua's surprise ph. 3 failure in ATTR-CM
Aug 29, 2026 1:35pm
Alnylam sees Amvuttra as potential standard of care in ATTR-CM
Aug 30, 2024 10:06am
At ESC, AstraZeneca shows Farxiga's benefits across indications
Aug 28, 2023 10:10am
AZ's Farxiga looks set to gain a key 2nd nod in heart failure
Aug 29, 2022 8:08am
